Screening for infectious diseases among newly arrived migrants in EU/EEA countries--varying practices but consensus on the utility of screening

Tommi Kärki, Christian Napoli, Flavia Riccardo, Massimo Fabiani, Maria Grazia Dente, Manuel Carballo, Teymur Noori, Silvia Declich, Tommi Kärki, Christian Napoli, Flavia Riccardo, Massimo Fabiani, Maria Grazia Dente, Manuel Carballo, Teymur Noori, Silvia Declich

Abstract

Screening is one possible tool for monitoring infectious diseases among migrants. However, there is limited information on screening programmes targeted for newly arrived migrants in EU/EEA countries. Our aim was to investigate the implementation, practices and usefulness of these programmes. We conducted a survey among country experts from EU/EEA countries and Switzerland, asking whether their countries had implemented screening programmes. We also estimated the association between the implementation of these programmes and the rate of asylum-seekers in the population. Of the countries, 16 (59%) had implemented screening programmes and 15 (56%) had national guidelines. The rate of asylum-seekers was associated with implementation of screening programmes (p = 0.014). Screening was performed most often for tuberculosis; most commonly on holding level, and was targeted to specific migrant groups in over half of the countries performing screening. Twenty-five of all the country experts (96%) considered screening among migrants useful, and 24 (92%) would welcome EU level guidelines for screening. The implementation of screening programmes varied, and the practices were different among countries. Our survey suggests, that establishing EU level guidelines for screening would be useful, although they would have to take into account differences between individual countries.

Figures

Figure 1
Figure 1
Infectious diseases screened for in countries with implemented screening programmes (n = 15).
Figure 2
Figure 2
The level for screening for each infectious disease in countries with implemented screening programmes (n = 15).
Figure 3
Figure 3
Expert opinions on the usefulness of screening and of potential actions taken on international level (n = 26).

References

    1. Vasileva K. 6.5% of the EU population are foreigners and 9.4% are born abroad. Eurostat. Stat. Focus. 2011;34:1–8.
    1. European Centre for Disease Prevention and Control (ECDC) Migrant Health: Background Note to the “ECDC Report on Migration and Infectious Diseases in the EU”. European Centre for Disease Prevention and Control; Stockholm, Sweden: 2009.
    1. International Organization for Migration (IOM) World Migration Report 2010: The Future of Migration: Building Capacities for Change. International Organization for Migration; Geneva, Switzerland: 2010.
    1. Riccardo F., Napoli C., Bella A., Rizzo C., Rota M.C., Dente M.G., de Santis S., Declich S. Syndromic surveillance of epidemic-prone diseases in response to an influx of migrants from North Africa to Italy, May to October 2011. [(accessed on 17 November 2011)];EuroSurveillance. 2011 16 Available online: .
    1. Rechel B., Mladovsky P., Ingleby D., Mackenbach J.P., McKee M. Migration and health in an increasingly diverse Europe. Lancet. 2013;381:1235–1245. doi: 10.1016/S0140-6736(12)62086-8.
    1. European Centre for Disease Prevention and Control (ECDC) Assessing the Burden of Key Infectious Diseases Affecting Migrant Populations in the EU/EEA. European Centre for Disease Prevention and Control; Stockholm, Sweden: 2014.
    1. Marschall T., Kretzschmar M., Mangen M.J., Schalm S. High impact of migration on the prevalence of chronic hepatitis B in the Netherlands. Eur. J. Gastroenterol. Hepatol. 2008;20:1214–1225. doi: 10.1097/MEG.0b013e32830e289e.
    1. Gushulak B.D., MacPherson D.W. Globalization of infectious diseases: The impact of migration. Clin. Infect. Dis. 2004;38:1742–1748. doi: 10.1086/421268.
    1. Vakali A., Patsoula E., Spanakos G., Danis K., Vassalou E., Tegos N., Economopoulou A., Baka A., Pavli A., Koutis C., et al. Malaria in Greece, 1975 to 2010. [(accessed on 22 November 2012)];EuroSurveillance. 2012 17 Available online: .
    1. World Health Organization Europe . The Vector-Borne Human Infections of Europe. Their Distribution and Burden on Public Health. World Health Organization Europe; Copenhagen, Denmark: 2004.
    1. Gushulak B., Pottie K., Roberts J.H., Torres S., DesMeules M. Migration and health in Canada: Health in the global village. Can. Med. Assoc. J. 2011;12:E952–E958. doi: 10.1503/cmaj.090287.
    1. Dara M., Gushulak B.D., Posey D.L., Zellweger J.P., Migliori G.B. The history and evolution of immigration medical screening for tuberculosis. Expert Rev. Anti-Infect. Ther. 2013;11:137–146. doi: 10.1586/eri.12.168.
    1. Klinkenberg E., Manissero D., Semenza J.C., Verver S. Migrant tuberculosis screening in the EU/EEA: Yield, coverage and limitations. Eur. Respir. J. 2009;34:1180–1189. doi: 10.1183/09031936.00038009.
    1. Pareek M., Baussano I., Abubakar I., Dye C., Lalvani A. Evaluation of immigrant tuberculosis screening in industrialized countries. Emerg. Infect. Dis. 2012;18:1422–1429. doi: 10.3201/eid1809.120128.
    1. Pottie K., Greenaway C., Feightner J., Welch V., Swinkels H., Rashid M., Narasiah L., Kirmayer L.J., Ueffing E., MacDonald N.E., et al. Evidence-based clinical guidelines for immigrants and refugees. Can. Med. Assoc. J. 2011;12:E824–E925. doi: 10.1503/cmaj.090313.
    1. SurveyMonkey Inc. Palo Alto, CA, USA. 2014. [(accessed on 2 September 2014)]. Available online: .
    1. United Nations Department of Economic and Social Affairs . Recommendations on Statistics of International Migration, Revision 1. UN DESA, Statistics Division; New York, NY, USA: 1998.
    1. StataCorp LP; College Station, TX, USA: 2009. Stata Statistical Software: Release 11 [Computer Program]
    1. Panchal R.K., Browne I., Monk P., Woltmann G., Haldar P. The effectiveness of primary care based risk stratification for targeted latent tuberculosis infection screening in recent immigrants to the UK: A retrospective cohort study. Thorax. 2014;69:354–362. doi: 10.1136/thoraxjnl-2013-203805.
    1. Rossi C., Schwartzman K., Oxlade O., Klein M.B., Greenaway C. Hepatitis B screening and vaccination strategies for newly arrived adult Canadian immigrants and refugees: A cost-effectiveness analysis. PLoS One. 2013;8 doi: 10.1371/journal.pone.0078548.
    1. Pareek M., Watson J.P., Ormerod L.P., Kon O.M., Woltmann G., White P.J., Abubakar I., Lalvani A. Screening of immigrants in the UK for imported latent tuberculosis: A multicentre cohort study and cost-effectiveness analysis. Lancet Infect. Dis. 2011;11:435–444. doi: 10.1016/S1473-3099(11)70069-X.
    1. Barniol J., Niemann S., Louis V.R., Brodhun B., Dreweck C., Richter E., Becher H., Haas W., Junghanss T. Transmission dynamics of pulmonary tuberculosis between autochthonous and immigrant sub-populations. BMC Infect. Dis. 2009;9 doi: 10.1186/1471-2334-9-197.
    1. Tafuri S., Martinelli D., Melpignano L., de Palma M., Quarto M., Prato R., Germinario C. Tuberculosis screening in migrant reception centers: Results of a 2009 Italian survey. Am. J. Infect. Control. 2011;39:495–499. doi: 10.1016/j.ajic.2010.10.013.
    1. Barnett E.D., Weld L.H., McCarthy A.E., So H., Walker P.F., Stauffer W., Cetron M. Spectrum of illness in international migrants seen at GeoSentinel clinics in 1997–2009, part 1: US-bound migrants evaluated by comprehensive protocol-based health assessment. Clin. Infect. Dis. 2013;56:913–924. doi: 10.1093/cid/cis1015.

Source: PubMed

3
订阅